APA
Oliynyk G., Ruiz-Pérez M. V., Sainero-Alcolado L., Dzieran J., Zirath H., Gallart-Ayala H., Wheelock C. E., Johansson H. J., Nilsson R., Lehtiö J. & Arsenian-Henriksson M. (2019). MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. : iScience.
Chicago
Oliynyk Ganna, Ruiz-Pérez María Victoria, Sainero-Alcolado Lourdes, Dzieran Johanna, Zirath Hanna, Gallart-Ayala Héctor, Wheelock Craig E, Johansson Henrik J, Nilsson Roland, Lehtiö Janne and Arsenian-Henriksson Marie. 2019. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. : iScience.
Harvard
Oliynyk G., Ruiz-Pérez M. V., Sainero-Alcolado L., Dzieran J., Zirath H., Gallart-Ayala H., Wheelock C. E., Johansson H. J., Nilsson R., Lehtiö J. and Arsenian-Henriksson M. (2019). MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. : iScience.
MLA
Oliynyk Ganna, Ruiz-Pérez María Victoria, Sainero-Alcolado Lourdes, Dzieran Johanna, Zirath Hanna, Gallart-Ayala Héctor, Wheelock Craig E, Johansson Henrik J, Nilsson Roland, Lehtiö Janne and Arsenian-Henriksson Marie. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. : iScience. 2019.